Northwest Biotherapeutics, Inc. (BST:NBYB)
Germany flag Germany · Delayed Price · Currency is EUR
0.2200
+0.0100 (4.76%)
At close: Jul 3, 2025

Northwest Biotherapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3123527447775831,026
Upgrade
Market Cap Growth
-48.89%-52.72%-4.28%33.17%-43.13%790.70%
Upgrade
Enterprise Value
3814207978096031,038
Upgrade
Last Close Price
0.220.310.650.780.581.27
Upgrade
PE Ratio
----3.70-
Upgrade
PS Ratio
228.78263.35425.38493.23660.04971.84
Upgrade
PB Ratio
-3.97-4.61-17.47-7.90-5.35-3.46
Upgrade
EV/Sales Ratio
-314.92455.93513.96682.10983.37
Upgrade
Debt / Equity Ratio
-0.81-0.85-0.97-0.25-0.31-0.05
Upgrade
Asset Turnover
0.050.050.070.050.030.06
Upgrade
Quick Ratio
0.030.030.050.060.110.03
Upgrade
Current Ratio
0.060.060.090.080.130.04
Upgrade
Return on Assets (ROA)
-151.76%-152.28%-117.23%-117.48%-90.17%-248.63%
Upgrade
Earnings Yield
-25.50%-23.02%-7.62%-12.65%27.00%-42.23%
Upgrade
FCF Yield
-16.29%-15.95%-6.94%-6.71%-6.68%-3.08%
Upgrade
Buyback Yield / Dilution
-11.99%-10.99%-10.17%-0.79%-38.99%-28.53%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.